ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Liabilities | ₹7,390 Cr | ₹1,309 Cr | ₹2,008 Cr |
What is the latest Total Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,390 Cr |
| Mar2024 | ₹1,309 Cr |
| Mar2023 | ₹2,008 Cr |
How is Total Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,390 Cr | 464.77 | |
| Mar2024 | ₹1,309 Cr | -34.85 | |
| Mar2023 | ₹2,008 Cr | - | |
Compare Total Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹16,089.3 Cr | 3.4% | 4.3% | -16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 3.4% |
4.3% |
-16.5% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses